Paolo Forte
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Paolo Forte has a total of 189 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Feo
Department of Biomedical Sciences, Humanitas University, Milan, Italy
10 shared publications - SriniVas R. Sadda
Doheny Eye Institute, Pasadena, California, USA
10 shared publications - Alberto Quarta
UCLA Doheny Eye Institute, Pasadena, California, USA
9 shared publications - Giulia Corradetti
Doheny Eye Institute, Pasadena, California
8 shared publications David Sarraf
7 shared publications- Giuseppe Querques
Ophthalmology Unit - Policlinic of Modena
6 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 44
Epivascular glia mimicking drusen in dry age related macular degeneration
- 23 October 2026
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 44
Open AccessEpivascular glia mimicking drusen in dry age related macular degeneration
- Open Access
- 19 October 2026
- Published by Elsevier in Ophthalmology Science
Foveal Threat Index: A Direction-Sensitive Biomarker of Ciliary Neurotrophic Factor Treatment Effects in Macular Telangiectasia Type 2
- 19 October 2026
- Published by Elsevier in Ophthalmology Science
Open AccessFoveal Threat Index: A Direction-Sensitive Biomarker of Ciliary Neurotrophic Factor Treatment Effects in Macular Telangiectasia Type 2
- Open Access
- 19 October 2026
- Published by Elsevier in Ophthalmology Science
Cavitation Phenotypes and Point-Wise Retinal Sensitivity in Macular Telangiectasia Type 2:A Post Hoc Analysis From the NTMT-03-A Trial
- 19 October 2026
- Published by Elsevier in Ophthalmology Science
Open AccessCavitation Phenotypes and Point-Wise Retinal Sensitivity in Macular Telangiectasia Type 2:A Post Hoc Analysis From the NTMT-03-A Trial
- Open Access
- 8 October 2026
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 293, 51-62
Interpretable Machine Learning for Course Prediction in Central Serous Chorioretinopathy Using Baseline Optical Coherence Tomography From a Multicenter Cohort
- 8 October 2026
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 293, 51-62
Open AccessInterpretable Machine Learning for Course Prediction in Central Serous Chorioretinopathy Using Baseline Optical Coherence Tomography From a Multicenter Cohort
- 1 October 2026
- Published by Wolters Kluwer Health in Retina
- Vol. 46 (10) , e111-e112
High-Resolution Optical Coherence Tomography of Bacillary Layer Detachment
Was not provided for this article.
- 1 October 2026
- Published by Wolters Kluwer Health in Retina
- Vol. 46 (10) , e111-e112
High-Resolution Optical Coherence Tomography of Bacillary Layer Detachment
Was not provided for this article.
- 29 September 2026
- Published by Elsevier in Experimental Eye Research
- Vol. 273
Geometric model for semi-automatic foveal localization based on the optic nerve head–fovea axis
- 29 September 2026
- Published by Elsevier in Experimental Eye Research
- Vol. 273
Geometric model for semi-automatic foveal localization based on the optic nerve head–fovea axis
- Open Access
- 23 September 2026
- Published by Elsevier in Ophthalmology Science
- Vol. 6 (12)
High-Resolution OCT of Basal Laminar Deposit Phenotypes and Retinal Pigment Epithelium Morphologic Changes in Age-Related Macular Degeneration
- 23 September 2026
- Published by Elsevier in Ophthalmology Science
- Vol. 6 (12)
Open AccessHigh-Resolution OCT of Basal Laminar Deposit Phenotypes and Retinal Pigment Epithelium Morphologic Changes in Age-Related Macular Degeneration
- 17 September 2026
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 292, 606-618
Ultrawidefield Optical Coherence Tomography Mapping of Foveal and Optic Nerve Head Topography Within Posterior Staphyloma in Pathologic Myopia
- 17 September 2026
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 292, 606-618
Ultrawidefield Optical Coherence Tomography Mapping of Foveal and Optic Nerve Head Topography Within Posterior Staphyloma in Pathologic Myopia
- 14 September 2026
- Published by Wiley in Acta Ophthalmologica
Accelerated biological ageing is associated with a large drusen burden
Purpose: To investigate the association between accelerated biological ageing, measured by Phenotypic Age (PhenoAge) and PhenoAge Acceleration (PhenoAgeAccel), and features of early and intermediate age‐related macular degeneration (AMD) in a population‐based cohort. Methods: This cross‐sectional study used data from the National Health and Nutrition Examination Survey. Biological age was estimated using the PhenoAge algorithm, a composite of routine blood biomarkers and chronological age, and PhenoAgeAccel was defined as the residual from regression of PhenoAge on chronological age. Retinal outcomes were drusen ≥500 μm (primary outcome), drusen ≥125 μm and pigmentary abnormalities. Associations were evaluated using logistic regression adjusted for biological sex, race/ethnicity, smoking, body mass index and diabetes. Results: A total of 5322 participants were included (mean age 59.4 ± 12.4 years; 50.4% female). Drusen ≥500 μm were present in 4.1%, drusen ≥125 μm in 10.2% and pigmentary abnormalities in 5.6%. PhenoAgeAccel > + 3 years was associated with higher odds of drusen ≥500 μm (OR: 1.56, 95%CI: 1.07–2.27, p = 0.022), whereas no association was observed for <−3 years. Each 1‐year increase in PhenoAgeAccel was associated with higher odds of drusen ≥500 μm (OR: 1.02, 95%CI: 1.00–1.04, p = 0.022). PhenoAgeAccel > + 3 years was also associated with drusen ≥125 μm (OR: 1.29, 95%CI: 1.00–1.65, p = 0.049), but not with pigmentary abnormalities. Conclusion: Accelerated biological ageing was associated with increased drusen burden, but not pigmentary abnormalities, suggesting that early structural features of AMD may reflect broader systemic ageing processes.
- 14 September 2026
- Published by Wiley in Acta Ophthalmologica
Accelerated biological ageing is associated with a large drusen burden
Purpose: To investigate the association between accelerated biological ageing, measured by Phenotypic Age (PhenoAge) and PhenoAge Acceleration (PhenoAgeAccel), and features of early and intermediate age‐related macular degeneration (AMD) in a population‐based cohort. Methods: This cross‐sectional study used data from the National Health and Nutrition Examination Survey. Biological age was estimated using the PhenoAge algorithm, a composite of routine blood biomarkers and chronological age, and PhenoAgeAccel was defined as the residual from regression of PhenoAge on chronological age. Retinal outcomes were drusen ≥500 μm (primary outcome), drusen ≥125 μm and pigmentary abnormalities. Associations were evaluated using logistic regression adjusted for biological sex, race/ethnicity, smoking, body mass index and diabetes. Results: A total of 5322 participants were included (mean age 59.4 ± 12.4 years; 50.4% female). Drusen ≥500 μm were present in 4.1%, drusen ≥125 μm in 10.2% and pigmentary abnormalities in 5.6%. PhenoAgeAccel > + 3 years was associated with higher odds of drusen ≥500 μm (OR: 1.56, 95%CI: 1.07–2.27, p = 0.022), whereas no association was observed for <−3 years. Each 1‐year increase in PhenoAgeAccel was associated with higher odds of drusen ≥500 μm (OR: 1.02, 95%CI: 1.00–1.04, p = 0.022). PhenoAgeAccel > + 3 years was also associated with drusen ≥125 μm (OR: 1.29, 95%CI: 1.00–1.65, p = 0.049), but not with pigmentary abnormalities. Conclusion: Accelerated biological ageing was associated with increased drusen burden, but not pigmentary abnormalities, suggesting that early structural features of AMD may reflect broader systemic ageing processes.